Skip to content
healthcare.dev

Amphetamine Extended-Release

NDC 62542-015, Amphetamine Extended-Release, tablet, orally disintegrating, from Neos Therapeutics, LP.

Product NDC
62542-015
Status
Listed
Labeler
Neos Therapeutics, LP
Dosage form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA204326
DEA schedule
CII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62542-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMPHETAMINE9.4 mg/1

Pharmacologic classes

Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]

Package NDCNDC-11Package
62542-015-306254200153030 BLISTER PACK in 1 CARTON (62542-015-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
62542-015-316254200153130 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62542-015-31)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/48d0f55c-f847-4d26-b2ed-94b5a2770228
  • NADAC price for package 62542001530

    GET /v1/drugs/nadac/62542001530

Use it

Look up 62542-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62542-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62542-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.